Dr. Rastogi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 Medical Plaza
#365B
Los Angeles, CA 90095Phone+1 310-954-2692- Is this information wrong?
Summary
- Anjay Rastogi, M.D., Ph.D, is Professor and Clinical Chief of Nephrology at the David Geffen School of Medicine at UCLA, Los Angeles, California. Dr. Rastogi is board certified in Nephrology and has a doctoral degree (Ph.D) in Pharmacology. Dr. Rastogi did his Internal Medicine residency and Nephrology fellowship at UCLA; he completed his graduate training under the mentorship of Nobel Laureate Professor, Louis Ignarro also at UCLA. Besides the Clinical Chief, he also serves as the Director of Nephrology Clinical Research Program, Medical Director of the ESRD | Dialysis Program, Living Kidney Donor Program, Fabry Program and PKD Program at UCLA. His research interests include cardiovascular disease, PKD, Fabry disease, anemia, diabetes and hypertension, especially in the CKD population; he has several ongoing clinical trials and studies including the NIH sponsored SPRINT study. He founded the CORE Kidney Program and the Bruin Beans Health Club at UCLA. He was awarded the UCLA Exceptional MD of the Year Award in 2014 for his demonstration of the UCLA values of Compassion, Respect, Excellence, Discovery, Integrity, and Teamwork.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Nephrology, 2003 - 2005
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 2000 - 2003
- University of California, Los AngelesPhD, Pharmacology, 1994 - 2000
- University of California, Los AngelesPh.D., Pharmacology, 1994 - 2000
- Sawai Man Singh Medical CollegeClass of 1993
Certifications & Licensure
- CA State Medical License 2003 - 2025
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Physician of the Year University of California, Los Angeles, 2014
Clinical Trials
- Tolvaptan Phase 3 Efficacy and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Start of enrollment: 2007 Jan 01
- Tolvaptan Extension Study in Participants With ADPKD Start of enrollment: 2010 May 26
- Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia Start of enrollment: 2010 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan.Tangri, N., Nekeman-Nan, C., Hong, L., Ozaki, A., Franzén, S., Sofue, T., Rastogi, A.> ;Advances in Therapy. 2024 Mar 1
- 1 citationsEffect of Intensive Blood Pressure Control on Kidney Outcomes: Long-Term Electronic Health Record-Based Post-Trial Follow-Up of SPRINT.Paul E Drawz, Kristin M Lenoir, Nayanjot Kaur Rai, Anjay Rastogi, Chi D Chu, Frederic F Rahbari-Oskoui, Paul K Whelton, George Thomas, Andrew McWilliams, Anil K Agarwa...> ;Clinical Journal of the American Society of Nephrology. 2023 Oct 25
- 2 citationsMultimodal efforts to slow the progression of chronic kidney disease in patients with type 2 diabetes mellitus.Anjay Rastogi, Matthew R Weir> ;Journal of Diabetes and Its Complications. 2023 Aug 1
- Join now to see all
Journal Articles
- A Practical Guide for Treatment of Rapidly Progressive ADPKD with TolvaptanRonald D Perrone, Anjay Rastogi, Terry Watnick, Arlene B Chapman, Michal Mrug, Vicente E Torres, Fouad T Chebib, Neera K Dahl, Peter C Harris, Journal of the American Society of Nephrology
- Published Ahead of PrintAnjay Rastogi, Glenn M Chertow, Journal of the American Society of Nephrology
- Long-term efficacy and safety of sucroferric oxyhydroxide in African American dialysis patientsS. M. Sprague, M. Ketteler, A. C. Covic, J. Floege, V. Rakov, S. Walpen, and A. Rastogi, Hemodial. Int., 1/1/2018
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- case of autosomal recessive Alport's syndromeFarid Arman, Misak Harutyunyan, Gurpreet Singh, Kevin C. Donohue, Maha Al baghdadi, Rohit Singhal, Niloofar Nobakht, Anjay Rastogi, ASN Kidney Week, Chicago, IL, 1/1/2018
- Light chain amyloidosis in a kidney donorHania Shakeri, Niloofar Nobakht, Shaker Qaqish, Anthony Sisk, Farid Arman, Ehsan Nobakht, Mohammad Kamgar, Anjay Rastogi, ASN Kidney Week, Chicago, IL, 1/1/2018
- A novel presentation of Fabry DiseaseFarid Arman, Peter D. Lymberopoulos, Niloofar Nobakht, Mohammad Kamgar, Ramy M. Hanna, Carl E. Schulze, Reza Khorsan, Jean Hou, Behnoud Beroukhim, Anjay Rastogi, ASN Kidney Week, Chicago, IL, 1/1/2018
- Join now to see all
Lectures
- EGFR antagonists in ADPKDKansas City, KS - 1/1/2018
- Velphoro Publication Steering CommitteeZurich, Switzerland - 1/1/2018
- Ambulatory Blood Pressure sub-studyDallas, TX - 1/1/2018
- Join now to see all
Other
- Renal Sympathetic Denervation for Resistant Hypertension: Rationale and ResultsSharma T, Talwar R, Goshtaseb K, and Rastogi A
1/1/2013 - Could You Have Prehypertension?Rastogi A, UCLA Division of Geriatrics Healthy Years newsletter
1/1/2008 - Take Steps Now to Preserve Your Kidney FunctionRastogi A, UCLA Division of Geriatrics Healthy Years newsletter
1/6/2007 - Join now to see all
Press Mentions
- UCLA Jonsson Comprehensive Cancer Center Researchers at ASH 2021 Annual Meeting and ExpositionDecember 14th, 2021
- ‘Long COVID’ Raises Kidney Damage RiskSeptember 14th, 2021
- XORTX Provides Overview and Update of Key ActivitiesApril 30th, 2020
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: